메뉴 건너뛰기




Volumn 17, Issue 3, 2004, Pages 232-243

Relation between structure, activity and adverse effects of quinolones;Relación entre estructura, actividad y efectos adversos de las quinolonas

Author keywords

[No Author keywords available]

Indexed keywords

4 QUINOLONE DERIVATIVE; 8 (3 AMINO 1 PYRROLIDINYL) 1 CYCLOPROPYL 7 FLUORO 9 METHYL 4 OXO 3 QUINOLIZINECARBOXYLIC ACID; CIPROFLOXACIN; CLINAFLOXACIN; ENOXACIN; FLEROXACIN; GARENOXACIN; GATIFLOXACIN; GEMIFLOXACIN; GREPAFLOXACIN; LOMEFLOXACIN; MOXIFLOXACIN; NALIDIXIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; NORFLOXACIN; PEFLOXACIN; PGE 4175997; PGE 9262932; PGE 9509924; PIPERACILLIN; PYRROLIDINE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLIZINE DERIVATIVE; QUINOLONE DERIVATIVE; SITAFLOXACIN; SPARFLOXACIN; TEMAFLOXACIN; TOSUFLOXACIN; TROVAFLOXACIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 9644303068     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (6)

References (68)
  • 1
    • 0017744584 scopus 로고
    • Development of antibacterial agents of the nalidixic acid type
    • Albrecht, R. Development of antibacterial agents of the nalidixic acid type. Prog Drug Res 1977; 21: 9-104.
    • (1977) Prog Drug Res , vol.21 , pp. 9-104
    • Albrecht, R.1
  • 3
    • 0014020719 scopus 로고
    • A critical evaluation of nalidixic acid in urinary-tract infections
    • Ronald, A.R., Turck, M., Petersdorf, R.G. A critical evaluation of nalidixic acid in urinary-tract infections. N Engl J Med 1966; 275: 1081-1089.
    • (1966) N Engl J Med , vol.275 , pp. 1081-1089
    • Ronald, A.R.1    Turck, M.2    Petersdorf, R.G.3
  • 5
    • 0019252702 scopus 로고
    • Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids
    • Koga, H., Itoh, A., Murayama, S., Suzue, S., Irikura, T. Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids. J Med Chem 1980; 23: 1358-1363.
    • (1980) J Med Chem , vol.23 , pp. 1358-1363
    • Koga, H.1    Itoh, A.2    Murayama, S.3    Suzue, S.4    Irikura, T.5
  • 6
    • 9344236011 scopus 로고    scopus 로고
    • Synthesis and structure-activity relationships of 2-pyridones: A novel series of potent DNA gyrase inhibitors as antibacterial agents
    • Li, Q., Chu, D.T., Claiborne, A. y cols. Synthesis and structure-activity relationships of 2-pyridones: A novel series of potent DNA gyrase inhibitors as antibacterial agents. J Med Chem 1996; 39; 3070-3088.
    • (1996) J Med Chem , vol.39 , pp. 3070-3088
    • Li, Q.1    Chu, D.T.2    Claiborne, A.3
  • 7
    • 0028316927 scopus 로고
    • Structure-activity and structure-side-effect relationships for the quinolone antibacterials
    • Domagala, J.M. Structure-activity and structure-side-effect relationships for the quinolone antibacterials. J Antimicrob Chemother 1994; 33: 685-706.
    • (1994) J Antimicrob Chemother , vol.33 , pp. 685-706
    • Domagala, J.M.1
  • 8
    • 0024255719 scopus 로고
    • The 4-quinolone antibiotics: Past, present and future
    • Stein, G.E. The 4-quinolone antibiotics: Past, present and future. Pharmacotherapy 1988; 8: 301-314.
    • (1988) Pharmacotherapy , vol.8 , pp. 301-314
    • Stein, G.E.1
  • 9
    • 0029886964 scopus 로고    scopus 로고
    • Quinolones: Structure-activity relationships and future predictions
    • Tillotson, G.S. Quinolones: Structure-activity relationships and future predictions. J Med Microbiol 1996; 44: 320-324.
    • (1996) J Med Microbiol , vol.44 , pp. 320-324
    • Tillotson, G.S.1
  • 10
    • 0033010428 scopus 로고    scopus 로고
    • Fluoroquinolone toxicity profiles: A review focusing on newer agents
    • Lipsky, B.A., Baker, C.A. Fluoroquinolone toxicity profiles: A review focusing on newer agents. Clin Infect Dis 1999; 28: 352-364.
    • (1999) Clin Infect Dis , vol.28 , pp. 352-364
    • Lipsky, B.A.1    Baker, C.A.2
  • 11
    • 0033081949 scopus 로고    scopus 로고
    • Mechanisms of fluoroquinolone resistance
    • Hooper, D.C. Mechanisms of fluoroquinolone resistance. Drug Resis Updates 1999; 2: 38-55.
    • (1999) Drug Resis Updates , vol.2 , pp. 38-55
    • Hooper, D.C.1
  • 14
    • 0034880316 scopus 로고    scopus 로고
    • Comparative antimicrobial spectrum and activity of BMS284756 (T-3811, a desfluoroquinolone) tested against 656 Enterobacteriaceae, including preliminary in vitro susceptibility test comparisons and development
    • Fix, A.M., Pfaller, M.A., Biedenbach, D.J., Beach, M.L., Jones, R.N. Comparative antimicrobial spectrum and activity of BMS284756 (T-3811, a desfluoroquinolone) tested against 656 Enterobacteriaceae, including preliminary in vitro susceptibility test comparisons and development. Int J Antimicrob Agents 2001; 18: 141-145.
    • (2001) Int J Antimicrob Agents , vol.18 , pp. 141-145
    • Fix, A.M.1    Pfaller, M.A.2    Biedenbach, D.J.3    Beach, M.L.4    Jones, R.N.5
  • 15
    • 0032937732 scopus 로고    scopus 로고
    • In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone
    • Takahata, M., Mitsuyama, J., Yamashiro, Y. y cols. In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone. Antimicrob Agents Chemother 1999; 43: 1077-1084.
    • (1999) Antimicrob Agents Chemother , vol.43 , pp. 1077-1084
    • Takahata, M.1    Mitsuyama, J.2    Yamashiro, Y.3
  • 17
    • 0034426122 scopus 로고    scopus 로고
    • Antibacterial spectrum of a novel des-fluoro(6)-quinolone, BMS284756
    • Fung-Tomc, J.C., Minassian, B., Kolek, B. y cols. Antibacterial spectrum of a novel des-fluoro(6)-quinolone, BMS284756. Antimicrob Agents Chemother 2000; 44: 3351-3356.
    • (2000) Antimicrob Agents Chemother , vol.44 , pp. 3351-3356
    • Fung-Tomc, J.C.1    Minassian, B.2    Kolek, B.3
  • 18
    • 0035017582 scopus 로고    scopus 로고
    • In vitro activities of three non-fluorinated quinolones against representatives bacterial isolates
    • Barry, A.L., Fuchs, P.C., Brown, S.D. In vitro activities of three non-fluorinated quinolones against representatives bacterial isolates. Antimicrob Agents Chemother 2001; 45: 1923-1927.
    • (2001) Antimicrob Agents Chemother , vol.45 , pp. 1923-1927
    • Barry, A.L.1    Fuchs, P.C.2    Brown, S.D.3
  • 19
    • 0034888431 scopus 로고    scopus 로고
    • The inhibition and selectivity of bacterial topoisomerases by BMS-284756 and its analogues
    • Lawrence, L.E., Wu, P., Fan, L. y cols. The inhibition and selectivity of bacterial topoisomerases by BMS-284756 and its analogues. J Antimicrob Chemother 2001; 48: 195-201.
    • (2001) J Antimicrob Chemother , vol.48 , pp. 195-201
    • Lawrence, L.E.1    Wu, P.2    Fan, L.3
  • 20
    • 0036118935 scopus 로고    scopus 로고
    • In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone
    • Yamakawa, T., Mitsuyama, J., Hayashi, K. In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone. J Antimicrob Chemother 2002; 49: 455-465.
    • (2002) J Antimicrob Chemother , vol.49 , pp. 455-465
    • Yamakawa, T.1    Mitsuyama, J.2    Hayashi, K.3
  • 21
    • 0030061794 scopus 로고    scopus 로고
    • Studies on 6-aminoquinolones: Synthesis and antibacterial evaluation of 6-amino-8-methylquinolones
    • Cecchetti, V., Fravolini, A., Lorenzini, M.C., Tabarrini, O., Terni, P., Xin, T. Studies on 6-aminoquinolones: Synthesis and antibacterial evaluation of 6-amino-8-methylquinolones. J Med Chem 1996; 39: 436-445.
    • (1996) J Med Chem , vol.39 , pp. 436-445
    • Cecchetti, V.1    Fravolini, A.2    Lorenzini, M.C.3    Tabarrini, O.4    Terni, P.5    Xin, T.6
  • 22
    • 0030972785 scopus 로고    scopus 로고
    • Chemometric methodologies in a quantitative structure-activity relationship study: The antibacterial activity of 6-aminoquinolones
    • Cecchetti, V., Fravolini, A., Lorenzini, M.C. y cols. Chemometric methodologies in a quantitative structure-activity relationship study: The antibacterial activity of 6-aminoquinolones. J Med Chem 1997; 40: 1698-1706.
    • (1997) J Med Chem , vol.40 , pp. 1698-1706
    • Cecchetti, V.1    Fravolini, A.2    Lorenzini, M.C.3
  • 23
    • 0029922437 scopus 로고    scopus 로고
    • Using SAR QSAR analysis to model the activity and structure of the quinolone-DNA complex
    • Llorente, B., Leclerc, F., Cedergren, R. Using SAR and QSAR analysis to model the activity and structure of the quinolone-DNA complex. Bio Med Chem 1996; 4: 61-71.
    • (1996) Bio Med Chem , vol.4 , pp. 61-71
    • Llorente, B.1    Leclerc, F.2    Cedergren, R.3
  • 24
    • 0029955365 scopus 로고    scopus 로고
    • Studies on quinolone antibacterials. IV. Structure-activity relationships of antibacterial activity and side effects for 5- and 8-substitued and 5,8-disubstitued-7(3-amino-1-pyrrolidinyl)-1-cyclopropil-1,4-dihydro-4- oxoquinoline-3-carboxylic acid
    • Yoshida, T., Yamamoto, Y., Orita, H. y cols. Studies on quinolone antibacterials. IV. Structure-activity relationships of antibacterial activity and side effects for 5- and 8-substitued and 5,8-disubstitued-7(3-amino-1- pyrrolidinyl)-1-cyclopropil-1,4-dihydro-4-oxoquinoline-3-carboxylic acid. Chem Pharm Bull (Tokyo) 1996; 44: 1074-1085.
    • (1996) Chem Pharm Bull (Tokyo) , vol.44 , pp. 1074-1085
    • Yoshida, T.1    Yamamoto, Y.2    Orita, H.3
  • 25
    • 0032812518 scopus 로고    scopus 로고
    • Anti-Toxoplasma gondii activities and structure-activity relationships of novel fluoroquinolones related to trovafloxacin
    • Kahn, A.A., Araujo, F.G., Brightly, K.E., Gootz, T.D., Remington, J.S. Anti-Toxoplasma gondii activities and structure-activity relationships of novel fluoroquinolones related to trovafloxacin. Antimicrob Agents Chemother 1999; 43: 1783-1787.
    • (1999) Antimicrob Agents Chemother , vol.43 , pp. 1783-1787
    • Kahn, A.A.1    Araujo, F.G.2    Brightly, K.E.3    Gootz, T.D.4    Remington, J.S.5
  • 26
    • 0033011810 scopus 로고    scopus 로고
    • Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: Effects of a C-8 methoxy group on survival in liquid media and in human macrophages
    • Zhao, B.Y, Pine, R., Domagala, J., Drlica, K. Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: Effects of a C-8 methoxy group on survival in liquid media and in human macrophages. Antimicrob Agents Chemother 1999; 43: 661-666.
    • (1999) Antimicrob Agents Chemother , vol.43 , pp. 661-666
    • Zhao, B.Y.1    Pine, R.2    Domagala, J.3    Drlica, K.4
  • 27
    • 0033053495 scopus 로고    scopus 로고
    • Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci
    • Jorgensen, J.H., Weigel, L.M., Ferraro, M.J., Swenson, J.M., Tenover, F.C. Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci. Antimicrob Agents Chemother 1999; 43: 329-334.
    • (1999) Antimicrob Agents Chemother , vol.43 , pp. 329-334
    • Jorgensen, J.H.1    Weigel, L.M.2    Ferraro, M.J.3    Swenson, J.M.4    Tenover, F.C.5
  • 28
    • 0031046694 scopus 로고    scopus 로고
    • Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: Selective targeting of gyrase or topoisomerase IV by quinolones
    • Pan, X.S., Fisher, M.L. Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: Selective targeting of gyrase or topoisomerase IV by quinolones. Antimicrob Agents Chemother 1997; 41: 471-474.
    • (1997) Antimicrob Agents Chemother , vol.41 , pp. 471-474
    • Pan, X.S.1    Fisher, M.L.2
  • 29
    • 0032930271 scopus 로고    scopus 로고
    • In vitro development of resistance to five quinolones and amoxicillin clavunate in Streptococcus pneumoniae
    • Davies, T.A., Pankuch, G.A., Dewasse, B.E., Jacobs, M.R., Appelbaum, P.C. In vitro development of resistance to five quinolones and amoxicillin clavunate in Streptococcus pneumoniae. Antimicrob Agents Chemother 1999; 43: 1177-1782.
    • (1999) Antimicrob Agents Chemother , vol.43 , pp. 1177-1782
    • Davies, T.A.1    Pankuch, G.A.2    Dewasse, B.E.3    Jacobs, M.R.4    Appelbaum, P.C.5
  • 30
    • 0032839851 scopus 로고    scopus 로고
    • Contribution of topoisomerase IV and DNA gyrase mutation in Streptococcus pneumoniae for resistance to novel fluoroquinolones
    • Pestova, E., Beyer, R., Cianciotto, N.P., Noskin, G.A., Peterson, L.R. Contribution of topoisomerase IV and DNA gyrase mutation in Streptococcus pneumoniae for resistance to novel fluoroquinolones. Antimicrob Agents Chemother 1999; 43: 2000-2004.
    • (1999) Antimicrob Agents Chemother , vol.43 , pp. 2000-2004
    • Pestova, E.1    Beyer, R.2    Cianciotto, N.P.3    Noskin, G.A.4    Peterson, L.R.5
  • 31
    • 0035023593 scopus 로고    scopus 로고
    • Contribution of the 8-methoxy group of gatifloxacin to resistance selectivity, target preference, and antibacterial activity against Streptococcus pneumoniae
    • Fukuda, H., Kishii, R., Takei, M., Hosaka, M. Contribution of the 8-methoxy group of gatifloxacin to resistance selectivity, target preference, and antibacterial activity against Streptococcus pneumoniae. Antimicrob Agents Chemother 2001; 45: 1649-1453.
    • (2001) Antimicrob Agents Chemother , vol.45 , pp. 1649-1453
    • Fukuda, H.1    Kishii, R.2    Takei, M.3    Hosaka, M.4
  • 32
    • 0035867057 scopus 로고    scopus 로고
    • Comparative in vitro and in vivo activity of the C-8 methoxy quinolone moxifloxacin and the C-8 chlorine quinolone BAY y-3118
    • Dalhoff, A. Comparative in vitro and in vivo activity of the C-8 methoxy quinolone moxifloxacin and the C-8 chlorine quinolone BAY y-3118. Clin Infect Dis 2001; 32 (Suppl. 1): S16-S22.
    • (2001) Clin Infect Dis , vol.32 , Issue.SUPPL. 1
    • Dalhoff, A.1
  • 33
    • 0008450171 scopus 로고    scopus 로고
    • The C-8 methoxy group of moxifloxacin decreases the propensity for quinolone resistance development in Staphylococcus aureus
    • Philadelphia; Abstr. 102
    • Dalhoff, A. The C-8 methoxy group of moxifloxacin decreases the propensity for quinolone resistance development in Staphylococcus aureus. 37th Annual Meeting of the Infectious Diseases Society of America, Philadelphia 1999; Abstr. 102.
    • (1999) 37th Annual Meeting of the Infectious Diseases Society of America
    • Dalhoff, A.1
  • 34
    • 0028859494 scopus 로고
    • In vitro antibacterial activity of DU-6859a, a new fluoroquinolone
    • Nakane, T., Iyobe, S., Sato, K., Mitsuhashi, S. In vitro antibacterial activity of DU-6859a, a new fluoroquinolone, Antimicrob Agents Chemother 1995; 39: 2822-2826.
    • (1995) Antimicrob Agents Chemother , vol.39 , pp. 2822-2826
    • Nakane, T.1    Iyobe, S.2    Sato, K.3    Mitsuhashi, S.4
  • 35
    • 0032784460 scopus 로고    scopus 로고
    • Structures of existing and new quinolones and relationship to bactericidal activity against Streptococcus pneumoniae
    • Mitsuyama, J. Structures of existing and new quinolones and relationship to bactericidal activity against Streptococcus pneumoniae, J Antimicrob Chemother 1999; 44: 201-207.
    • (1999) J Antimicrob Chemother , vol.44 , pp. 201-207
    • Mitsuyama, J.1
  • 36
    • 0029837525 scopus 로고    scopus 로고
    • Mechanism of differential activities of ofloxacin enantiomers
    • Morrissey, I., Hoshino, K., Sato, K. y cols. Mechanism of differential activities of ofloxacin enantiomers. Antimicrob Agents Chemother 1996; 40: 1775-1784.
    • (1996) Antimicrob Agents Chemother , vol.40 , pp. 1775-1784
    • Morrissey, I.1    Hoshino, K.2    Sato, K.3
  • 37
    • 10144258659 scopus 로고    scopus 로고
    • Structure-activity relationships of quinolone agents against mycobacteria: Effect of structural modifications at the 8 position
    • Renau, T.E., Gage, J.W., Dever, J.A. y cols. Structure-activity relationships of quinolone agents against mycobacteria: Effect of structural modifications at the 8 position. Antimicrob Agents Chemother 1996; 40: 2363-2368.
    • (1996) Antimicrob Agents Chemother , vol.40 , pp. 2363-2368
    • Renau, T.E.1    Gage, J.W.2    Dever, J.A.3
  • 38
    • 0035884910 scopus 로고    scopus 로고
    • Quinolone molecular structure-activity relationships: What we have learned about improving antimicrobial activity?
    • Peterson, L.R. Quinolone molecular structure-activity relationships: What we have learned about improving antimicrobial activity? Clin Infect Dis 2001; 33 (Supl. 3): S180-S186.
    • (2001) Clin Infect Dis , vol.33 , Issue.SUPPL. 3
    • Peterson, L.R.1
  • 39
    • 0031755687 scopus 로고    scopus 로고
    • Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract
    • Piddock, L.J., Jonhson, M., Ricci, V., Hill, S.L. Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract. Antimicrob Agents Chemother 1998; 42: 2956-2960.
    • (1998) Antimicrob Agents Chemother , vol.42 , pp. 2956-2960
    • Piddock, L.J.1    Jonhson, M.2    Ricci, V.3    Hill, S.L.4
  • 40
    • 0031685173 scopus 로고    scopus 로고
    • Advances in the macrolides and quinolones
    • Boswell, F.J., Wise R. Advances in the macrolides and quinolones. Infect Dis Clin North Am 1998; 12: 647-670.
    • (1998) Infect Dis Clin North Am , vol.12 , pp. 647-670
    • Boswell, F.J.1    Wise, R.2
  • 41
    • 0345337645 scopus 로고    scopus 로고
    • SB-265805 (LB20304a): Structure-activity relationship of the oxime-derivatized pyrrolidine. The importance of the oximinoalkyl group on in vitro antibacterial activity and pharmacokinetics
    • San Diego
    • Hong, C.Y., Kim, Y.K., Nam, D.-H. y cols. SB-265805 (LB20304a): Structure-activity relationship of the oxime-derivatized pyrrolidine. The importance of the oximinoalkyl group on in vitro antibacterial activity and pharmacokinetics. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego 1998; F-095.
    • (1998) 38th Interscience Conference on Antimicrobial Agents and Chemotherapy
    • Hong, C.Y.1    Kim, Y.K.2    Nam, D.-H.3
  • 42
    • 0344474928 scopus 로고    scopus 로고
    • SB-265805 (LB20304a): The synergistic effect of the methyloxime and aminomethyl groups of the C7-pyrrolidine on in vitro activity
    • San Diego
    • Hong, C.Y., Kim, Y.K., Jang, J.H., Kim, M.Y. SB-265805 (LB20304a): The synergistic effect of the methyloxime and aminomethyl groups of the C7-pyrrolidine on in vitro activity. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego 1998; F-096.
    • (1998) 38th Interscience Conference on Antimicrobial Agents and Chemotherapy
    • Hong, C.Y.1    Kim, Y.K.2    Jang, J.H.3    Kim, M.Y.4
  • 43
    • 0033839497 scopus 로고    scopus 로고
    • The fluoroquinolones antibacterials: Past, present and future perspectives
    • Appelbaum, P.C., Hunter, P.A. The fluoroquinolones antibacterials: Past, present and future perspectives. Int J Antimicrb Agents 2000; 16: 5-15.
    • (2000) Int J Antimicrb Agents , vol.16 , pp. 5-15
    • Appelbaum, P.C.1    Hunter, P.A.2
  • 44
    • 0034017776 scopus 로고    scopus 로고
    • Intracellular targets of moxifloxacin: A comparison with other fluoroquinolones
    • Pestova, E., Millichap, J.J., Noskin, G.A., Peterson, L.R. Intracellular targets of moxifloxacin: A comparison with other fluoroquinolones. J Antimicrob Chemother 2000; 45: 583-590.
    • (2000) J Antimicrob Chemother , vol.45 , pp. 583-590
    • Pestova, E.1    Millichap, J.J.2    Noskin, G.A.3    Peterson, L.R.4
  • 45
    • 0033993695 scopus 로고    scopus 로고
    • A convenient assay for estimating the possible involvement of efflux of fluoroquinolones by Streptococcus pneumoniae and Staphylococcus aureus: Evidence for disminished moxifloxacin, sparfloxacin and trovafloxacin efflux
    • Beyer, R., Pestova, E., Millichap, J.J., Noskin, G.A., Peterson, L.R. A convenient assay for estimating the possible involvement of efflux of fluoroquinolones by Streptococcus pneumoniae and Staphylococcus aureus: Evidence for disminished moxifloxacin, sparfloxacin and trovafloxacin efflux. Antimicrob Agents Chemother 2000; 44: 798-801.
    • (2000) Antimicrob Agents Chemother , vol.44 , pp. 798-801
    • Beyer, R.1    Pestova, E.2    Millichap, J.J.3    Noskin, G.A.4    Peterson, L.R.5
  • 47
    • 0033979885 scopus 로고    scopus 로고
    • Engineering the specifity of antibacterial fluoroquinolones: Benzenesulfonamide modifications at C-7 of ciprofloxacin change its primary target in Streptococcus pneumoniae from topoisomerase IV to gyrase
    • Alovero, F.L., Pan, X.S., Morris, J.A., Manzo, R.H., Fisher, L.M. Engineering the specifity of antibacterial fluoroquinolones: Benzenesulfonamide modifications at C-7 of ciprofloxacin change its primary target in Streptococcus pneumoniae from topoisomerase IV to gyrase. Antimicrob Agents Chemother 2000; 44: 320-325.
    • (2000) Antimicrob Agents Chemother , vol.44 , pp. 320-325
    • Alovero, F.L.1    Pan, X.S.2    Morris, J.A.3    Manzo, R.H.4    Fisher, L.M.5
  • 48
    • 0032957758 scopus 로고    scopus 로고
    • Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae
    • Lister, P.D., Sanders, C.C. Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae. J Antimicrob Chemother 1999; 43: 79-86.
    • (1999) J Antimicrob Chemother , vol.43 , pp. 79-86
    • Lister, P.D.1    Sanders, C.C.2
  • 49
    • 0033533871 scopus 로고    scopus 로고
    • Synthesis and antimicrobial activity oh 4-H-4-oxoquinolizines derivaties: Consequences of structural modifications at the C-8 position
    • Ma, Z., Chu, D.T., Cooper, C.S. y cols. Synthesis and antimicrobial activity oh 4-H-4-oxoquinolizines derivaties: Consequences of structural modifications at the C-8 position. J Med Chem 1999; 42: 4203-4213.
    • (1999) J Med Chem , vol.42 , pp. 4203-4213
    • Ma, Z.1    Chu, D.T.2    Cooper, C.S.3
  • 50
    • 0342646918 scopus 로고    scopus 로고
    • The 2-pyridone antibacterial agents: Bacterial topoisomerase inhibitors
    • Li, Q., Mitscher, L.A., Shen, L.L. The 2-pyridone antibacterial agents: Bacterial topoisomerase inhibitors. Med Res Rev 2000; 20: 231-293.
    • (2000) Med Res Rev , vol.20 , pp. 231-293
    • Li, Q.1    Mitscher, L.A.2    Shen, L.L.3
  • 51
    • 10544254692 scopus 로고    scopus 로고
    • Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases
    • Blanche, F., Cameron, B., Bernard, F.X. y cols. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases. Antimicrob Agents Chemother 1996; 40: 2714-2720.
    • (1996) Antimicrob Agents Chemother , vol.40 , pp. 2714-2720
    • Blanche, F.1    Cameron, B.2    Bernard, F.X.3
  • 55
    • 0028818518 scopus 로고
    • Tolerability of fluoroquinolone antibiotics: Past, present and future
    • Ball, P., Tillotson, G. Tolerability of fluoroquinolone antibiotics: Past, present and future. Drug Safety 1995; 13: 343-358.
    • (1995) Drug Safety , vol.13 , pp. 343-358
    • Ball, P.1    Tillotson, G.2
  • 57
    • 0029142723 scopus 로고
    • Classification and structure-activity relationships of fluoroquinolones
    • Bryskier, A., Chantot, J.F. Classification and structure-activity relationships of fluoroquinolones. Drug 1995; 49 (Suppl. 2): 16-28.
    • (1995) Drug , vol.49 , Issue.SUPPL. 2 , pp. 16-28
    • Bryskier, A.1    Chantot, J.F.2
  • 58
    • 0025876187 scopus 로고
    • Quinolone-cation interactions: A review. DICP
    • Lomaestro, B.M., Bailie, G.R. Quinolone-cation interactions: A review. DICP. Ann Pharmacother 1991; 25: 1249-1258.
    • (1991) Ann Pharmacother , vol.25 , pp. 1249-1258
    • Lomaestro, B.M.1    Bailie, G.R.2
  • 59
    • 0002113676 scopus 로고
    • Pharmacokinetics and tissue penetration of fluoroquinolones
    • Sanders, E.W., Sanders, C.C. (Eds.). Physicians and Scientist Publ. Co., Glenview, IL
    • Shentag, J.J., Nix, D.E. Pharmacokinetics and tissue penetration of fluoroquinolones. En: Sanders, E.W., Sanders, C.C. (Eds.). Fluoroquinolones in the treatment of infectious diseases. Physicians and Scientist Publ. Co., Glenview, IL 1990; 29-44.
    • (1990) Fluoroquinolones in the Treatment of Infectious Diseases , pp. 29-44
    • Shentag, J.J.1    Nix, D.E.2
  • 60
    • 0026341296 scopus 로고
    • Overview of fluoroquinolone safety
    • Wolfson, J.S., Hooper, D.C. Overview of fluoroquinolone safety. Am J Med 1991; 91 (Suppl. 6A): 153S-161S.
    • (1991) Am J Med , vol.91 , Issue.SUPPL. 6A
    • Wolfson, J.S.1    Hooper, D.C.2
  • 63
    • 0026576555 scopus 로고
    • Mutagenicity of quinolone antibacterials
    • Fort, F.L. Mutagenicity of quinolone antibacterials. Drug Safety 1992; 7: 214-222.
    • (1992) Drug Safety , vol.7 , pp. 214-222
    • Fort, F.L.1
  • 64
    • 0025869379 scopus 로고
    • Side effects of quinolones: Comparison between quinolones and other antibiotics
    • Norrby, S.R. Side effects of quinolones: Comparison between quinolones and other antibiotics. Eur J Clin Microbiol Infect Dis 1991; 10: 378-383.
    • (1991) Eur J Clin Microbiol Infect Dis , vol.10 , pp. 378-383
    • Norrby, S.R.1
  • 65
    • 0023740775 scopus 로고
    • Design, synthesis, and properties of (4S)-7-(4-amino-2-substitued- pyrrolinyl) quinolone-3-carboxylic acids
    • Rosen, T., Chu, D.T.W., Lico, I.M., Fernandes, P.B., Marsh, K., Shen, L. Design, synthesis, and properties of (4S)-7-(4-amino-2-substitued-pyrrolinyl) quinolone-3-carboxylic acids. J Med Chem 1988; 31: 1598-1611.
    • (1988) J Med Chem , vol.31 , pp. 1598-1611
    • Rosen, T.1    Chu, D.T.W.2    Lico, I.M.3    Fernandes, P.B.4    Marsh, K.5    Shen, L.6
  • 66
    • 0023716946 scopus 로고
    • Specific toxicologic aspects of the quinolones
    • Christ, W., Lehnert, T., Ulbrich, B. Specific toxicologic aspects of the quinolones. Rev Infect Dis 1988; 10 (Suppl. 1): S141-S146.
    • (1988) Rev Infect Dis , vol.10 , Issue.SUPPL. 1
    • Christ, W.1    Lehnert, T.2    Ulbrich, B.3
  • 68
    • 0001743848 scopus 로고
    • Advers effects of the fluoroquinolones
    • Halkin, H. Advers effects of the fluoroquinolones. Rev Infect Dis 1988; 10 (Suppl. 1): S258-S261.
    • (1988) Rev Infect Dis , vol.10 , Issue.SUPPL. 1
    • Halkin, H.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.